Brief: Active Biotech Announces Final Outcome Of Company’S Rights Issue
Sept 7 (Reuters) - Active Biotech AB publ ACTI.ST :
* ACTIVE BIOTECH ANNOUNCES FINAL OUTCOME OF THE COMPANY’S
RIGHTS
ISSUE
* IN TOTAL, 46,832,077 SHARES WERE SUBSCRIBED FOR,
CORRESPONDING
TO APPROXIMATELY 86 PERCENT OF RIGHTS ISSUE
* WILL THEREBY RAISE APPROXIMATELY SEK 46,8 MILLION BEFORE
DEDUCTION OF ISSUE EXPENSES.
Source text for Eikon: ID:nMFN54bBWL
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million